The Company has until October 31, 2023, to request a hearing. It is noted that Anghami's continued listing on Nasdaq remains a key priority. Accordingly, the Company intends to request in a timely manner a hearing before the Panel, at which it will seek continued listing pending its return to compliance with the listing requirements on either The Nasdaq Global Market or The Nasdaq Capital Market. Anghami's hearing request will stay the suspension of trading and delisting of the Company's ordinary shares pending the conclusion of the hearing process. Consequently, the Company's ordinary shares will remain listed on The Nasdaq Global Market at least until the Panel renders a decision following the hearing. Alternatively, in the event that the Panel determines that continued listing on The Nasdaq Global Market is not warranted, the Company may seek to transfer the listing of its ordinary shares to The Nasdaq Capital Market.